Medical Devices
Technology
Health

DexCom

$118.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.51 (3.94%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell DexCom and other stocks, options, ETFs, and crypto commission-free!

About

DexCom, Inc. Common Stock, also called DexCom, is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Read More Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share,and Mobile apps. The company was founded by John F. Burd in May 1999 and is headquartered in San Diego, CA.

Employees
2,800
Headquarters
San Diego, California
Founded
1999
Market Cap
10.83B
Price-Earnings Ratio
ā€”
Dividend Yield
0.00
Average Volume
1.27M
High Today
$118.99
Low Today
$114.45
Open Price
$115.16
Volume
287.26K
52 Week High
$156.16
52 Week Low
$86.55

Collections

Medical Devices
Technology
Health
Medical
Manufacturing
US
North America

News

Yahoo FinanceMay 7

See what the IHS Markit Score report has to say about Dexcom Inc.

Dexcom Inc NASDAQ/NGS:DXCM View full report here! Summary ETFs holding this stock are seeing positive inflows but are weakening Bearish sentiment is low Economic output in this company's sector is expanding Bearish sentiment Short interest | Positive Short interest is low for DXCM with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling e...

162
NasdaqMay 2

DexCom (DXCM) Q1 2019 Earnings Call Transcript

Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q1 2019 Earnings Call May. 01, 2019 , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Welcome to the DexCom first-quarter 2019 earnings release conference call. My name is Adrianne, and I'll be your operator for today's call. [Operator instructions] Please note, this conference is being recorded. I'll now turn the call over to Matt Dolan. Matt Dolan, you may begin. Matt Dolan -- Vice P...

83
NasdaqMay 2

DexCom (DXCM) Beats on Q1 Earnings, Hikes '19 Guidance

DexCom, Inc. DXCM reported adjusted loss of 5 cents per share in the first quarter of 2019, significantly narrower than the Zacks Consensus Estimate of a loss of 17 cents per share. Further, the figure was narrower than the year-ago quarter's loss of 32 cents per share. Total revenues surged 52.1% to $280.5 million on a year-over-year basis and also surpassed the Zacks Consensus Estimate by 14%. Rising volumes across all channels along with the increasing global awareness of the benefits of real-time CGM...

29

Earnings

-$0.33
-$0.04
$0.25
$0.54
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
ā€”
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.